Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.470
0.00 (0.00%)
Mar 4, 2025, 3:00 PM EST
Silence Therapeutics Employees
Silence Therapeutics had 109 employees as of December 31, 2023. The number of employees decreased by 13 or -10.66% compared to the previous year.
Employees
109
Change (1Y)
-13
Growth (1Y)
-10.66%
Revenue / Employee
$372,914
Profits / Employee
-$390,595
Market Cap
223.85M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Endo Inc. | 2,931 |
Elite Pharmaceuticals | 64 |
Glass House Brands | 413 |
Northwest Biotherapeutics | 25 |
CytoDyn | 9 |
SANUWAVE Health | 31 |
Silence Therapeutics News
- 2 days ago - Silence Therapeutics to Webcast Presentation at the Leerink Partners Global Healthcare Conference - Business Wire
- 7 days ago - Silence Therapeutics plc (SLN) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Silence Therapeutics plc 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Silence Therapeutics PLC (SLNCF) Reports Full Year 2024 Financial Results with Strong Cash ... - GuruFocus
- 8 days ago - Silence Therapeutics Reports Full Year 2024 Financial Results and Provides Business Update - Business Wire
- 20 days ago - Redmile Group, LLC Acquires Significant Stake in Silence Therapeutics PLC - GuruFocus
- 22 days ago - Silence Therapeutics to Report Fourth Quarter and Full Year 2024 Results on February 27, 2025 - Business Wire
- 23 days ago - Lombard Odier Asset Management's Strategic Acquisition in Silence Therapeutics PLC - GuruFocus